Fate Therapeutics
FATE
#8952
Rank
โ‚ฌ99.16 M
Marketcap
0,87ย โ‚ฌ
Share price
-6.58%
Change (1 day)
-87.59%
Change (1 year)

P/S ratio for Fate Therapeutics (FATE)

P/S ratio as of March 2025 (TTM): 8.04

According to Fate Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.3392. At the end of 2024 the company had a P/S ratio of 30.2.

P/S ratio history for Fate Therapeutics from 2013 to 2024

PS ratio at the end of each year

Year P/S ratio Change
202430.2420.86%
20235.80-42.99%
202210.2-89.82%
2021100-60.36%
202025281.87%
2019139-20.75%
2018175123.55%
201778.3231.94%
201623.6-40.72%
201539.8
2014N/A-100%
2013132

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
5.82-27.63%๐Ÿ‡บ๐Ÿ‡ธ USA
3.10-61.45%๐Ÿ‡บ๐Ÿ‡ธ USA
4.62-42.54%๐Ÿ‡บ๐Ÿ‡ธ USA
382 4,648.07%๐Ÿ‡บ๐Ÿ‡ธ USA
4.61-42.62%๐Ÿ‡บ๐Ÿ‡ธ USA